Nearly two-thirds of drug developers rely on functional service provider (FSP) outsourcing for their clinical research initiatives, according to industry research conducted by the PPD clinical research business of Thermo Fisher Scientific. FSP outsourcing is proving a popular choice for clinical research because it offers an effective response to four key industry challenges.

1. The proliferation of vendors involved in the clinical research process.

2. The perennial need to optimize drug development timelines and bring products to market faster.

3. Unprecedented high demand and limited supply of qualified talent.

4. The need to maintain positive relationships with the best sites to be regarded as a “sponsor of choice.”

Explore recent case studies in which customers turned to PPD clinical research services to overcome their challenges and accelerate success via our functional service partnership model.